CONGENITAL INFECTION

CONGENITAL INFECTION was reported 62 times

CONGENITAL INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 1 0.0008
1 Sulfonamide Antibacterial [EPC] 1 0.0003
2 Quinolone Antimicrobial [EPC] 1 0.0001
3 Human Immunoglobulin G [EPC] 2 0.0001
4 Progesterone [EPC] 2 0.0001
5 Lipid-based Polyene Antifungal [EPC] 1 0.0001
6 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0001
7 Polyene Antifungal [EPC] 2 0.0000
8 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
9 Protease Inhibitor [EPC] 1 0.0000
10 Macrolide Antimicrobial [EPC] 1 0.0000
11 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
12 Vitamin D [EPC] 5 0.0000
13 Vitamin B12 [EPC] 5 0.0000
14 Cardiac Glycoside [EPC] 1 0.0000
15 Catecholamine [EPC] 1 0.0000
16 Vitamin C [EPC] 5 0.0000
17 Integrin Receptor Antagonist [EPC] 1 0.0000
18 Progestin [EPC] 3 0.0000
19 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
20 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
21 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
22 Expectorant [EPC] 1 0.0000
23 Corticosteroid [EPC] 5 0.0000
24 Opioid Agonist [EPC] 1 0.0000
25 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
26 Benzodiazepine [EPC] 2 0.0000
27 Insulin Analog [EPC] 1 0.0000
28 Atypical Antipsychotic [EPC] 1 0.0000
29 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
30 Platelet Aggregation Inhibitor [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000